Regenxbio Inc. (RGNX) insider buying and SEC filings
Regenxbio Inc. · CIK 1590877
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- Fiscal year end
- Dec 31
- Former names
- ReGenX Biosciences, LLC
Insider activity in the last 12 months
Bought
$950K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$940K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 26–27, 2026 | Open-market purchase | Gregory Austin Ciongoli (Director) bought 102,603 shares between Aug 26 and Aug 27 at about $9.25 ($950K) in an open-market purchase. Holdings up 665% to 118,035 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 27, 2026 |
| Jul 2, 2026 | Planned (10b5-1) | Steve Pakola (Chief Medical Officer) sold 2,161 shares at $13.64 ($29K), marked as a 10b5-1 plan trade. Holdings down 1% to 213,009 shares. | SEC filing Filed Jul 6, 2026 |
| Jun 29–Jul 1, 2026 | Planned (10b5-1) | Steve Pakola (Chief Medical Officer) sold 56,333 shares between Jun 29 and Jul 1 at about $12.23 ($689K), marked as a 10b5-1 plan trade. Holdings down 21% to 213,009 shares. | SEC filing Filed Jul 1, 2026 |
| May 11, 2026 | Planned (10b5-1) | Steve Pakola (Chief Medical Officer) sold 15,309 shares at about $11.02 ($169K), marked as a 10b5-1 plan trade. Holdings down 6% to 232,617 shares. | SEC filing Filed May 13, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | Steve Pakola (Chief Medical Officer) sold 5,124 shares at $10.35 ($53K), marked as a 10b5-1 plan trade. Holdings down 2% to 247,926 shares. | SEC filing Filed Mar 12, 2026 |
33 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RGNX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.